首页> 美国卫生研究院文献>PLoS Genetics >Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
【2h】

Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone

机译:骨中FGF-23的血清磷酸盐非依赖性功能的遗传证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Maintenance of physiologic phosphate balance is of crucial biological importance, as it is fundamental to cellular function, energy metabolism, and skeletal mineralization. Fibroblast growth factor-23 (FGF-23) is a master regulator of phosphate homeostasis, but the molecular mechanism of such regulation is not yet completely understood. Targeted disruption of the Fgf-23 gene in mice (Fgf-23−/−) elicits hyperphosphatemia, and an increase in renal sodium/phosphate co-transporter 2a (NaPi2a) protein abundance. To elucidate the pathophysiological role of augmented renal proximal tubular expression of NaPi2a in Fgf-23−/− mice and to examine serum phosphate–independent functions of Fgf23 in bone, we generated a new mouse line deficient in both Fgf-23 and NaPi2a genes, and determined the effect of genomic ablation of NaPi2a from Fgf-23−/− mice on phosphate homeostasis and skeletal mineralization. Fgf-23−/−/NaPi2a−/− double mutant mice are viable and exhibit normal physical activities when compared to Fgf-23−/− animals. Biochemical analyses show that ablation of NaPi2a from Fgf-23−/− mice reversed hyperphosphatemia to hypophosphatemia by 6 weeks of age. Surprisingly, despite the complete reversal of serum phosphate levels in Fgf-23−/−/NaPi2a−/−, their skeletal phenotype still resembles the one of Fgf23−/− animals. The results of this study provide the first genetic evidence of an in vivo pathologic role of NaPi2a in regulating abnormal phosphate homeostasis in Fgf-23−/− mice by deletion of both NaPi2a and Fgf-23 genes in the same animal. The persistence of the skeletal anomalies in double mutants suggests that Fgf-23 affects bone mineralization independently of systemic phosphate homeostasis. Finally, our data support (1) that regulation of phosphate homeostasis is a systemic effect of Fgf-23, while (2) skeletal mineralization and chondrocyte differentiation appear to be effects of Fgf-23 that are independent of phosphate homeostasis.
机译:维持生理性磷酸盐平衡具有至关重要的生物学重要性,因为它对细胞功能,能量代谢和骨骼矿化至关重要。成纤维细胞生长因子23(FGF-23)是磷酸稳态的主要调节剂,但这种调节的分子机理尚未完全明了。小鼠Fgf-23基因的靶向破坏(Fgf-23 -/-)引起高磷酸盐血症,并导致肾脏钠/磷酸盐共转运蛋白2a(NaPi2a)蛋白丰度增加。为了阐明NaPi2a在Fgf-23 -// 小鼠中肾小管近端肾小管表达增强的病理生理作用,并检查骨骼中Fgf23的血清磷酸盐非依赖性功能,我们建立了一个新的小鼠系Fgf-23和NaPi2a基因,并确定了基因组消融Fgf-23 -// 小鼠NaPi2a对磷酸盐稳态和骨骼矿化的影响。与Fgf-23 -/--/- / NaPi2a -/-双重突变小鼠是可行的,并表现出正常的体育活动>动物。生化分析表明,从Fgf-23 -/-小鼠切除NaPi2a到6周龄时可将高磷酸盐血症逆转为低磷酸盐血症。出人意料的是,尽管Fgf-23 -/- / NaPi2a -/-中的血清磷酸盐水平完全逆转,但它们的骨骼表型仍然类似于Fgf23 - / − 动物。这项研究的结果提供了第一个遗传证据,表明NaPi2a在体内病理上的作用是通过缺失NaPi2a和Fgf-23基因来调节Fgf-23 -/-小鼠的异常磷酸稳态。同一只动物。双重突变体中骨骼异常的持续性表明,Fgf-23会独立于系统性磷酸盐稳态而影响骨骼矿化。最后,我们的数据支持(1)调节磷酸盐稳态是Fgf-23的全身作用,而(2)骨骼矿化和软骨细胞分化似乎是Fgf-23的作用,与磷酸盐稳态无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号